SCYX - Rasio utang marang kapitalisasi buku scynexis.com

The experienced management of SCYNEXIS, Inc. (SCYX) has successfully implemented innovative antimycotics, as evidenced by the upward trend. Financial leverage levels relative to balance sheet capital verify the strength of this trend, and 0.03 shows the level of this metric. While CMO molecule synthesis outsourcing creates sterility risks, stable demand for biotechnology renders the asset a defensive asset during recessionary periods.

SCYX (SCYNEXIS) riwayat Utang marang nilai buku saka 04.07.2022 nganti 26.10.2026

Rincian metrik lan analitis perusahaan scynexis.com (SCYX)

- rega lan prakiraan konsensus rega:

Rega saham SCYNEXIS|SCYX - Prakiraan konsensus analis

- data kapitalisasi pasar:

Nilai pasar SCYX|SCYX - Nilai Dipunlarasaken Utang lan Kas

- data kapitalisasi buku:

Aset Bersih saben Siji Saham SCYNEXIS|SCYX - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku scynexis.com|SCYX - Total Aset Perusahaan

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas SCYNEXIS, Inc.|SCYX - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal SCYNEXIS|SCYX - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku SCYX

Ringkesan analitik perusahaan:SCYX - Scynexis

The metric is calculated as the ratio of total liabilities to the current market value of equity. This metric assesses the future sustainability of the financing structure by determining the business's degree of dependence on borrowed funds. The optimization of SCYNEXIS, Inc. (SCYX) logistics chains reduces operational risks, which indirectly supports the stability of this ratio. By analyzing the level of debt concentration within the balance sheet capitalization, an investor can discern the balance between financial security and leverage efficiency.

Pesaing SCYNEXIS, Inc.